[2P-343] Effects of the glycosylation of IL-34 on the differentiation of monocytic cell with B cell stimulating activity

^〇Masaki Magari¹, Chisato Okamoto¹, Sayaka Ogawa¹, Naoki Kanayama¹, Naoya Hatano¹, Hiroshi Tokumitsu¹ (Grad. Sch. Interdiscip. Sci. and Eng. in Health Syst., Okayama Univ.)

The 95th Annual Meeting of the Japanese Biochemical Society

[2P-344（1T13a-03）] Mycobacterium leprae synthesizes mycolic acid by metabolizing triacylglycerol derived from host cells

^〇Kazunari Tanigawa¹, Yasuhiro Hayashi², Akira Kawashima³, Mitsuo Kiriya³, Yasuhiro Nakamura¹, Yoko Fujiwata³, Nagatoshi Fujiwara⁴, Ken Karasawa¹, Koichi Suzuki³ (1.Faculty of Pharma-Science, Teikyo University, 2.Faculty of Agriculture, University of Miyazaki, 3.Faculty of Medical Technology, Teikyo University, 4.Faculty of Contemporary Human Life Science, Tezukayama University)

The 95th Annual Meeting of the Japanese Biochemical Society

[2P-345（2T13a-04）] Mechanisms of mitocryptide-2 on lipopolysaccharide-induced multiorgan injury

^〇Hirokazu Tanaka¹, Tomoyuki Miyaji¹, Hakuu Fujiwara¹, Yosito Takamuro¹, Takenori Yamada¹, Hiroki Morikawa¹, Tatuya Hattori¹, Yosiaki Kiso¹, Hidehito Mukai¹ (Laboratory of Peptide Science, Graduate School of Bio-Science, Nagahama Institute of Bio-Science and Technology)

The 95th Annual Meeting of the Japanese Biochemical Society

[2P-346] The role of secreated gingipains from Porphyromonas gingivalis in increasing permeability of human cerebral microvascular endothelial cells

^〇Saori Nonaka¹ (Department of Pharmacology, Faculty of Pharmacy, Yasuda Women's University)

The 95th Annual Meeting of the Japanese Biochemical Society

[2P-347（3T11a-05）] Mucosal Protection against Pathogens with Injectable Vaccines.

^〇Ryotarou Mitsumata¹, Nagisa Nakata¹, Tomohiro Narahara¹, Asumi Kanda¹ (Vaccine & Biomedicine Dept. Denka Innovation Center Denka Co., Ltd.)

The 95th Annual Meeting of the Japanese Biochemical Society

[2P-348] Studies on nectriatide derivative that enhances the antifungal activity of amphotericinB

^〇Ryosuke Miyake¹, Keisuke Kobayashi¹, Kenichiro Nagai¹, Shinichi Nishimura², Hiroshi Tomoda¹, Taichi Ohshiro¹ (1.Graduate School of Pharmaceutical Sciences, Kitasato University, 2.Graduate School of Agricultural and Life Sciences, The University of Tokyo)

The 95th Annual Meeting of the Japanese Biochemical Society

[2P-349（3T11a-06）] Suitable Adjuvant for Recombinant Norovirus-like Particle Vaccine.

^〇Asumi Kanda¹, Nagisa Nakata¹, Takenori Oikawa¹, Ryotarou Mitsumata¹ (Vaccine & Biomedicine Dept. Denka Co., Ltd.)

The 95th Annual Meeting of the Japanese Biochemical Society

[2P-350（1T13a-04）] Regulation of influenza type A virus infection by a novel inhibitory peptide against CaMKII.

^〇Shinichiro Hama¹, Miho Takahashi¹, Kiyotaka Nishikawa¹ (Doshisha Univ., Grad. School of Life and Med., Mol. Life Sci.)

The 95th Annual Meeting of the Japanese Biochemical Society

[2P-351] Identification of factors for HIV-1 capsid core formation with optimal stability

^〇Naoki Kishimoto¹, Tamae Hirano¹, Satoshi Miura¹, Ayaka Irie¹, Nobutoki Takamune², Shogo Misumi¹ (1.Department of Environmental and Molecular Health Sciences, school of Pharmacy, Kumamoto University, 2.Kumamoto innovative development organization, Kumamoto University)

The 95th Annual Meeting of the Japanese Biochemical Society

[2P-352] Suppressive effects of seric acid and ferulic acid derivative on macrophage hyperactivation

^〇Yuto Nakata¹, Kensi Yosimura¹, Tatsuo Katagiri², Toshihiro Murata³, Syouhei Yamauchi¹, Takaya Nakano¹ (1.Univ. TOYAMA. Department of Pharmaceutical Sciences Biology Lab, 2.Univ. TOYAMA. Institute of liberal arts and sciences. Biology Lab, 3.Tohoku Pharmaceutical University, Department of Pharmacognosy)

The 95th Annual Meeting of the Japanese Biochemical Society